The deal, expected to close in the second half of 2026, comes as Kenvue's Tylenol political fight is heating up.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback